mark cuban pharmacy glp-1 Cuban's Cost Plus partners with telehealth firm to offer employers obesity care drugs Mark Cuban discusses the manufacturing

While LBM loss appears to be less pronounced than FBM loss in many studies, the clinical significance of even modest reductions in skeletal muscle remains uncertain, particularly in older adults or individuals at risk of sarcopenia

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved for type 2 diabetes management (under the brand name Ozempic) and chronic weight management (Wegovy)

GLP-1 s also inhibit gastric emptying and induce gastroparesis, which induces satiety and reduces appetite and food intake, therefore limiting weight gain [1]

Your insights could help others feel more confident with their GLP-1 treatment

Nat Chem Biol 5:749757